Guardant Health (GH) Competitors

Fresenius Medical Care (NYSE:FMS) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, community ranking, dividends, analyst recommendations, institutional ownership, earnings and risk.

Do analysts prefer FMS or GH?

Fresenius Medical Care currently has a consensus target price of $25.30, suggesting a potential upside of 9.57%. Guardant Health has a consensus target price of $40.60, suggesting a potential upside of 10.75%. Given Guardant Health's stronger consensus rating and higher possible upside, analysts clearly believe Guardant Health is more favorable than Fresenius Medical Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Guardant Health	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has stronger valuation & earnings, FMS or GH?

Fresenius Medical Care has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care	$19.24B	0.70	$540.07M	$1.21	19.08
Guardant Health	$563.95M	8.03	-$479.45M	-$4.24	-8.65

Does the media prefer FMS or GH?

In the previous week, Guardant Health had 10 more articles in the media than Fresenius Medical Care. MarketBeat recorded 10 mentions for Guardant Health and 0 mentions for Fresenius Medical Care. Guardant Health's average media sentiment score of 0.33 beat Fresenius Medical Care's score of 0.00 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Fresenius Medical Care	Neutral
Guardant Health	Neutral

Is FMS or GH more profitable?

Fresenius Medical Care has a net margin of 3.43% compared to Guardant Health's net margin of -74.02%. Fresenius Medical Care's return on equity of 6.04% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care	3.43%	6.04%	2.69%
Guardant Health	-74.02%	-1,200.44%	-29.88%

Does the MarketBeat Community prefer FMS or GH?

Fresenius Medical Care received 141 more outperform votes than Guardant Health when rated by MarketBeat users. However, 70.07% of users gave Guardant Health an outperform vote while only 54.66% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
Fresenius Medical Care	Outperform Votes 422 54.66%	Underperform Votes 350 45.34%
Guardant Health	Outperform Votes 281 70.07%	Underperform Votes 120 29.93%

Which has more risk and volatility, FMS or GH?

Fresenius Medical Care has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500.

Do institutionals & insiders believe in FMS or GH?

8.4% of Fresenius Medical Care shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 5.5% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Guardant Health beats Fresenius Medical Care on 10 of the 18 factors compared between the two stocks.